Corient Capital Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $480K | Buy |
6,444
+489
| +8% | +$36.4K | 0.04% | 348 |
|
|
2022
Q2 | $444K | Sell |
5,955
-373
| -6% | -$27.8K | 0.03% | 372 |
|
|
2022
Q1 | $809K | Buy |
6,328
+420
| +7% | +$53.7K | 0.05% | 281 |
|
|
2021
Q4 | $793K | Buy |
5,908
+208
| +4% | +$27.9K | 0.05% | 277 |
|
|
2021
Q3 | $779K | Buy |
5,700
+216
| +4% | +$29.5K | 0.06% | 261 |
|
|
2021
Q2 | $585K | Buy |
5,484
+572
| +12% | +$61K | 0.04% | 326 |
|
|
2021
Q1 | $442K | Buy |
4,912
+440
| +10% | +$39.6K | 0.04% | 340 |
|
|
2020
Q4 | $413K | Sell |
4,472
-2,556
| -36% | -$236K | 0.04% | 310 |
|
|
2020
Q3 | $725K | Sell |
7,028
-464
| -6% | -$47.9K | 0.08% | 204 |
|
|
2020
Q2 | $759K | Buy |
7,492
+3,608
| +93% | +$366K | 0.09% | 197 |
|
|
2020
Q1 | $261K | Buy |
3,884
+208
| +6% | +$14K | 0.04% | 318 |
|
|
2019
Q4 | $201K | Buy |
+3,676
| New | +$201K | 0.03% | 431 |
|